Analyst Briefing Presentation on the Global Neurostimulation Market to be Held on 8th Oct 2009

Wilmington, DE, October 08, 2009 --(PR.com)-- The Healthcare practice at MarketsandMarkets is pleased to announce its Analyst Briefing Presentation on the Global Neurostimulation Market to be held on 8th Oct.

The global market for neurostimulation products is expected to be worth $3.6 billion in 2009. Spinal cord stimulator forms the largest segment of this market with estimated annual revenue of $2.5 billion in 2009; followed by the deep brain stimulator market with an estimated $520 million in the same year.

The neurostimulation market is driven mainly by technology advancements, rising consumer awareness, rising age-related neurological disorders, improved clinical outcomes, long-term cost-effectiveness, increased FDA approvals for clinical trials, and the development of sophisticated implantable neurostimulation devices. Currently, there is a huge influx of new players entering into the market, thus leading to increased investments and R&D activities.

This analyst briefing focuses on the neurostimulation market over the period 2009-2014.The agenda for the briefing includes discussion on key high growth market, marking the growth trend in the product, application, and technology market for neurostimulation. Furthermore, a briefing will be conducted on the competitive scenario and geographic opportunities for the similar topic. It analyzes the major opportunities for the global neurostimulation market; and also evaluates the major trends in the macro- and micro-markets with respect to different geographic regions.

Contact their representative to sponsor this report

About MarketsandMarkets
MarketsandMarkets is a research and consulting firm that publishes 120 market reports per year. Each strategically analyzed report contains 250 pages of valuable market data, including more than 100 market data summary tables and in-depth, five-level segmentation for each of the products, services, applications, technologies, ingredients and stakeholders categories. Our reports also analyze about 200 patents, over 50 companies and micro markets that are mutually exclusive and collectively exhaustive.

###